PDLI - PDLバイオファ―マ (PDL BioPharma Inc.)

PDLIのニュース

   Silver Point Capital L.P. Acquires 640,000 Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) Stock  2020/12/16 11:38:41 Watchlist News
PDL BioPharma, Inc. (NASDAQ:PDLI) major shareholder Silver Point Capital L.P. bought 640,000 shares of the firm’s stock in a transaction that occurred on Monday, December 14th. The stock was purchased at an average cost of $2.62 per share, with a total value of $1,676,800.00. The acquisition was disclosed in a filing with the Securities & […]
   PDL Announces Timeline for Voluntarily Delisting from Nasdaq  2020/12/08 21:05:00 PR Newswire
INCLINE VILLAGE, Nev., Dec. 8, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has formally notified The Nasdaq Stock Market, Inc. of its intent to delist the Company's common stock from the Nasdaq Global Select Market ("Nasdaq")….
   David W. Gryska Sells 75,000 Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) Stock  2020/12/07 09:12:41 Watchlist News
PDL BioPharma, Inc. (NASDAQ:PDLI) Director David W. Gryska sold 75,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 3rd. The shares were sold at an average price of $2.52, for a total value of $189,000.00. Following the completion of the sale, the director now owns 30,337 shares in the company, […]
   PDL BioPharma reports Q3 results (NASDAQ:PDLI)  2020/11/11 10:38:27 Seeking Alpha
PDL BioPharma (NASDAQ:PDLI): Q3 GAAP EPS of -$0.64. Revenue of $7.1M (-12.3% Y/Y) Press Release
   PDL BioPharma (NASDAQ:PDLI) Shares Down 5.2%  2020/10/21 10:36:45 Zolmax News
PDL BioPharma, Inc. (NASDAQ:PDLI)’s share price traded down 5.2% during trading on Monday . The company traded as low as $2.20 and last traded at $2.20. 755,649 shares traded hands during mid-day trading, a decline of 36% from the average session volume of 1,182,237 shares. The stock had previously closed at $2.32. A number of […]
   Silver Point Capital L.P. Acquires 640,000 Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) Stock  2020/12/16 11:38:41 Watchlist News
PDL BioPharma, Inc. (NASDAQ:PDLI) major shareholder Silver Point Capital L.P. bought 640,000 shares of the firm’s stock in a transaction that occurred on Monday, December 14th. The stock was purchased at an average cost of $2.62 per share, with a total value of $1,676,800.00. The acquisition was disclosed in a filing with the Securities & […]
   PDL Announces Timeline for Voluntarily Delisting from Nasdaq  2020/12/08 21:05:00 PR Newswire
INCLINE VILLAGE, Nev., Dec. 8, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has formally notified The Nasdaq Stock Market, Inc. of its intent to delist the Company's common stock from the Nasdaq Global Select Market ("Nasdaq")….
   David W. Gryska Sells 75,000 Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) Stock  2020/12/07 09:12:41 Watchlist News
PDL BioPharma, Inc. (NASDAQ:PDLI) Director David W. Gryska sold 75,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 3rd. The shares were sold at an average price of $2.52, for a total value of $189,000.00. Following the completion of the sale, the director now owns 30,337 shares in the company, […]
   PDL BioPharma reports Q3 results (NASDAQ:PDLI)  2020/11/11 10:38:27 Seeking Alpha
PDL BioPharma (NASDAQ:PDLI): Q3 GAAP EPS of -$0.64. Revenue of $7.1M (-12.3% Y/Y) Press Release
   PDL BioPharma (NASDAQ:PDLI) Shares Down 5.2%  2020/10/21 10:36:45 Zolmax News
PDL BioPharma, Inc. (NASDAQ:PDLI)’s share price traded down 5.2% during trading on Monday . The company traded as low as $2.20 and last traded at $2.20. 755,649 shares traded hands during mid-day trading, a decline of 36% from the average session volume of 1,182,237 shares. The stock had previously closed at $2.32. A number of […]
   PDL BioPharma reports Q3 results (NASDAQ:PDLI)  2020/11/11 10:38:27 Seeking Alpha
PDL BioPharma (NASDAQ:PDLI): Q3 GAAP EPS of -$0.64. Revenue of $7.1M (-12.3% Y/Y) Press Release
   PDL BioPharma (NASDAQ:PDLI) Shares Down 5.2%  2020/10/21 10:36:45 Zolmax News
PDL BioPharma, Inc. (NASDAQ:PDLI)’s share price traded down 5.2% during trading on Monday . The company traded as low as $2.20 and last traded at $2.20. 755,649 shares traded hands during mid-day trading, a decline of 36% from the average session volume of 1,182,237 shares. The stock had previously closed at $2.32. A number of […]
   Reviewing PDL BioPharma (NASDAQ:PDLI) & Acorda Therapeutics (NASDAQ:ACOR)  2020/10/20 10:04:42 Zolmax News
PDL BioPharma (NASDAQ:PDLI) and Acorda Therapeutics (NASDAQ:ACOR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, institutional ownership, risk and analyst recommendations. Earnings & Valuation This table compares PDL BioPharma and Acorda Therapeutics’ revenue, earnings per share […]
   PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital  2020/09/09 12:30:00 PR Newswire
INCLINE VILLAGE, Nev., Sept. 9, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the closing of the sale of its wholly owned subsidiaries Noden Pharma DAC and Noden Pharma USA (collectively "Noden") to Stanley Capital. The total value of the…
   PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties to SWK Holdings Corporation  2020/08/31 13:00:00 PR Newswire
INCLINE VILLAGE, Nev., Aug. 31, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a definitive agreement for the sale of three royalty interests for Kybella®, Zalviso®, and Coflex® (collectively the "Royalties") to SWK…

calendar